A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

NCT06810583 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Acute Myeloid Leukemia
Lymphoblastic Leukemia in Children

Interventions

DRUG: Dalbavancin
DRUG: Fluoroquinolone (either ciprofloxacin or levofloxacin at the discretion of the treating clinician)

Sponsor

St. Jude Children's Research Hospital